U.S. Pharmaceuticals & Biotech Most Popular Stocks

Exelixis

Market Cap: US$10.5b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

BioMarin Pharmaceutical

Market Cap: US$10.3b

A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.

Ionis Pharmaceuticals

Market Cap: US$10.2b

A commercial-stage biotechnology company, provides RNA-targeted medicines in the United States.

Exact Sciences

Market Cap: US$10.2b

Provides cancer screening and diagnostic test products in the United States and internationally.

Moderna

Market Cap: US$10.1b

A biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally.

Roivant Sciences

Market Cap: US$10.0b

A clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines and technologies.

Revvity

Market Cap: US$9.8b

Provides health sciences solutions, technologies, and services.

Qiagen

Market Cap: US$9.8b

Provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally.

BridgeBio Pharma

Market Cap: US$9.7b

A commercial-stage biopharmaceutical company, discovers, creates, tests, and delivers transformative medicines to treat patients who suffer from genetic diseases and cancers.

Madrigal Pharmaceuticals

Market Cap: US$9.5b

A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.

Elanco Animal Health

Market Cap: US$9.3b

An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.

Verona Pharma

Market Cap: US$9.2b

A biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs.

Halozyme Therapeutics

Market Cap: US$8.8b

A biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States and internationally.

Corcept Therapeutics

Market Cap: US$8.8b

Engages in discovery and development of medication for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.

Caris Life Sciences

Market Cap: US$8.6b

An artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally.

Avantor

Market Cap: US$8.2b

Engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.

Revolution Medicines

Market Cap: US$8.1b

A clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers.

Bio-Techne

Market Cap: US$8.0b

Develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide.

Jazz Pharmaceuticals

Market Cap: US$7.8b

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.

Bio-Rad Laboratories

Market Cap: US$7.5b

Manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America.

Stevanato Group

Market Cap: US$7.4b

Engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific.

Charles River Laboratories International

Market Cap: US$7.4b

Charles River Laboratories International, Inc.

Regencell Bioscience Holdings

Market Cap: US$7.2b

Operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong.

Repligen

Market Cap: US$7.0b

A life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally.

Rhythm Pharmaceuticals

Market Cap: US$6.4b

A commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases.

Avidity Biosciences

Market Cap: US$6.2b

A biopharmaceutical company, engages in the delivery of RNA therapeutics called antibody oligonucleotide conjugates (AOCs).

Legend Biotech

Market Cap: US$6.1b

Through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe.

Axsome Therapeutics

Market Cap: US$5.9b

A biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States.

Cytokinetics

Market Cap: US$5.8b

A late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases in the United States.

Nuvalent

Market Cap: US$5.7b

A clinical-stage biopharmaceutical company, engages in the development of therapies for patients with cancer.

Semnur Pharmaceuticals

Market Cap: US$5.6b

Develops and markets non-opioid drugs to treat back pain.

CRISPR Therapeutics

Market Cap: US$5.6b

A gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform.

Metsera

Market Cap: US$5.5b

A clinical-stage biotechnology company, develops injectable and oral nutrient stimulated hormone analog peptides to treat obesity, overweight, and related diseases.

TG Therapeutics

Market Cap: US$5.2b

A commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally.

Merus

Market Cap: US$5.2b

A clinical-stage immuno-oncology company, engages in the development of antibody therapeutics in the Netherlands.

Bruker

Market Cap: US$4.9b

Develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally.